发明名称 |
Pharmaceutical compositions for hepatitis C viral protease inhibitors |
摘要 |
Disclosed are pharmaceutical compositions of hepatitis C viral protease inhibitors having improved bioavailability, and methods of using these compositions for inhibiting the replication of the hepatitis C virus (HCV) and for the treatment of an HCV infection. These compositions include co-solvent systems, lipid based systems, solid dispersions and granulations, and all comprise the hepatitis C viral protease inhibitor, at least one pharmaceutically acceptable amine and optionally one or more additional ingredients.
|
申请公布号 |
US6828301(B2) |
申请公布日期 |
2004.12.07 |
申请号 |
US20030357919 |
申请日期 |
2003.02.04 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
CHEN SHIRLYNN;MEI XIAOHUI |
分类号 |
A61K47/10;A61K9/107;A61K9/14;A61K9/48;A61K31/4709;A61K38/00;A61K38/55;A61K47/12;A61K47/14;A61K47/16;A61K47/18;A61K47/20;A61K47/22;A61K47/26;A61K47/32;A61K47/34;A61K47/38;A61K47/44;A61P1/16;A61P31/12;(IPC1-7):A61K47/18;A61K38/05 |
主分类号 |
A61K47/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|